The clitoris contributes to the normal female sexual response cycle. A significance of cyclic guanosine monophosphate (GMP) has been assumed in the control of clitoral vascular smooth muscle. As only a few investigations on the physiology of the vascular and non-vascular clitoral tissue have been carried out, knowledge on the mechanisms controlling this particular female genital organ is still vague. It has been suggested that human clitoral corpus cavernosum smooth muscle is regulated by nitric oxide (NO)/cyclic GMP and related key enzymes, such as NO synthases (NOSs) and the phosphodiesterase type 5 (PDE5). The present study evaluated in the human clitoris, by means of immunohistochemistry, the expression and distribution of key enzymes of the cyclic GMP pathway, such as the endothelial NOS, PDE2, PDE11 and cyclic GMP-dependent protein kinase type I (cGKI) in relation to the PDE5. Immunohistochemistry revealed the presence of PDE2, PDE5 and cGKI in the smooth muscle wall of blood vessels transversing the supepithelial and stromal space. Immunosignals specific for PDE2 were also identified in interstitial-like cells located in the basal epithelial layer. Staining for PDE11A was observed in single nerve trunks located in the clitoral stroma. The results are in favor of a role of the cyclic GMP signaling in the control of clitoral blood flow. It seems likely that PDE2 and PDE11 are also involved in the mechanism of local (neuro)transmission in the clitoris.
Introduction
Since 2004, the issue of women's sexual health, including female sexual function and dysfunction, have become predominant topics, not only to clinicians in the field of sexual medicine, but also to the community of basic researchers and pharmacologists. As a result, our knowledge on the physiology of the female sexual response, the pathophysiology of female sexual dysfunction, and pharmacological options to treat disturbances of female arousal and orgasmic function has rapidly increased. 1 The clitoris, together with the vagina and labia, has a central role in the mechanism of the female sexual response and perception of external sensory stimulation leading to normal arousal and, finally, orgasm. During the arousal phase, an increase in blood flow leading to vasocongestion and an engorgement of the clitoris, vagina and labia occurs. 2 It has been shown that pathological alterations of the structure of the clitoris are often associated with an impairment in sexual function, such as dyspareunia, arousal and orgasmic difficulties. 3, 4 Up until today, only a few detailed investigations on the physiology of the vascular and non-vascular clitoral tissue have been carried out. [5] [6] [7] Thus, the interaction of biochemical mediators and key enzymes assumed to be involved in signal transduction in the clitoris and the process of clitoral tumescence still remains to be elucidated. Cyclic nucleotide phosphodiesterase (PDE) isoenzymes, a heterogenous group of hydrolytic enzymes showing specific distribution in human tissues, are known to have a central role in cellular signal transduction. 8 Consequently, PDEs are considered important pharmacological targets and PDE isoenzymes have been isolated and characterized from various organs of the human genitourinary tract, including the human clitoris.
6,7,9-12 Park et al., 6 using a biochemical approach (ion exchange chromatography), demonstrated the presence of PDE5 in cultured human clitoral corpus cavernosum smooth muscle cells. They also showed that the hydrolysis of cyclic guanosine monophosphate (GMP) in both a crude extract of clitoral cells and a partially purified enzyme preparation was inhibited by the PDE5 inhibitors sildenafil and zaprinast, and concluded that the pathway controlling human clitoral corpus cavernosum smooth muscle is dependent on PDE5 activity. 6 Later, a pioneer study conducted by Oelke et al. 7 demonstrated by means of immunohistochemistry and molecular biology (real-time PCR) the expression and distribution of PDE4 (cyclic AMP PDE) and PDE5 (cyclic GMP PDE) in clitoral tissue. PDE4 was mainly observed in the non-vascular smooth musculature of the corpus cavernosum clitoris, the sinusoidal endothelial and subendothelial layers, as well as in nerve fibers innervating the tissue, PDE5 was limited to the smooth muscle of the clitoral erectile tissue. Immunosignals indicating the presence of PDE3 (cyclic AMP PDE, inhibited by cyclic GMP) were registered to a certain degree only in the clitoral epidermis. The authors concluded that, in the human clitoris, cyclic GMP PDE isoenzymes may have a function in the cyclic nucleotidemediated control of smooth muscle tone. 7 However, their study was limited solely to PDE3, PDE4 and PDE5. As it has been assumed that the synthesis and release of nitric oxide (NO) and the activity of cyclic GMP-binding proteins might be of importance in the control of clitoral smooth muscle, it was the aim of the present study to investigate in the human clitoris, by means of immunohistochemistry, the expression of some key enzymes of the cyclic GMP signaling, such as the cyclic GMP-binding PDE2 (cyclic AMP PDE), PDE11 (cyclic AMP/cyclic GMP PDE, dual substrate PDE), endothelial NO synthase (eNOS) and cyclic GMPdependent protein kinase G type I (cGKI) and their relation to PDE5.
Materials and methods

Tissue source and handling
In accordance with the regulations of the local ethical committee of the Hannover Medical School, clitoral tissue from the mid to proximal portion was obtained within 4-6 h postmortem from four female cadavers (age at death 18 years-42 years). Subjects had no known histories of diseases related to sexual dysfunction. Following excision, the tissue specimens were immediately placed in an ice-cold solution of 4% formaldehyde in phosphate-buffered saline (PBS; pH 7.4).
Immunohistochemistry
Clitoral tissue specimens were immersion-fixated for 4 h in an ice-cold solution of 4% formaldehyde in PBS (pH 7.4) and rinsed three times over 24 h with ice-cold PBS containing 15% sucrose. Specimens were embedded in Tissue-Tec (Miles Laboratories, Elkhart, IN, USA) and then rapidly frozen in isopentane at À40 1C. The tissue was sectioned to slices of 8-10 mm thickness and thawmounted onto glass slides. The sections were incubated for 2 h in PBS supplemented with 0.2% Triton X-100 and 1% bovine serum albumin, followed by an incubation for 24 h (at room temperature) with the primary antibodies (anti-eNOS, -sm a-actin, -PDE2, -PDE5, -cGK and -vimentin) in a proper dilution (anti-a-actin: 1:400, anti-eNOS: 1:1000, anti-PDE2/PDE5: 1:250, anti-cGK: 1:250, anti-vimentin: 1:40). After rinsing the sections with PBS, either fluorescein isothiocyanate-or Texas Red-labeled secondary antibodies (dilution 1:80 and 1:160, respectively) were applied and allowed to incubate the sections for 2 h. Thereafter, sections were mounted using phenylendiamine. Visualization was commenced using a laser microscope (Olympus, Tokyo, Japan) and imaging performed using the ViewFinder Lite program (version 2.0, Pixera, Egham, UK).
Antibody source
Antibodies directed against PDE2A, PDE5A and PDE11A were purchased from FabGennix (Frisco, TX, USA), the anti-cGKI AB was from Calbiochem (La Jolla, CA, USA), the anti-smooth muscle a-actin, -vimentin and -eNOS antibodies were from Sigma BioSciences (St Louis, MO, USA). Texas Red and Fluorescein dye conjugated F(ab) 2 fragments were obtained from Jackson Immunoresearch Laboratories (West Grove, PA, USA).
Results
Immunolocalization of PDE2, PDE5, PDE11, cGKI, eNOS and vimentin in the human clitoris Examination of numerous sections at different levels revealed multiple small sized arteries transversing the subepidermal and sinusoidal space (corpus cavernosum) of the clitoris. The smooth muscle Cyclic GMP binding proteins in the human clitoris S Ückert et al component of the corpus cavernosum clitoris became more prominent in the area under the subepidermal region. The smooth muscle of the vessel walls exhibited strong immunoreaction for a-actin and the cyclic GMP-binding PDE2 (cyclic AMP PDE) (Figure 1a ). This observation appeared consistent in all tissue sections examined. Clitoral sections stained for PDE5 and the cGKI exhibited strong immunofluorescence in vascular smooth muscle cells (Figures 1c and d) . No signals specific for PDE2 or cGK were detected in non-vascular clitoral smooth muscle or the epidermal multilayer. (Figures 2a-c) .
Immunostaining was registered in both the bodies and prolongations of the cells (Figures 3a and b) . No immunosignals specific for PDE5 were seen in the IC-like cells. In some of the cells, PDE2 was found co-localized with vimentin, a specific feature of ICs and neurons, thereby confirming earlier findings describing immunolabeling for ICs in cardiac tissue and the urogenital tract (Figure 3c ). [13] [14] [15] [16] [17] Staining specific for PDE11A (dual-substrate PDE) was observed in single nerve trunks located in the clitoral stroma (Figure 1f) . In contrast, no labeling indicating PDE2 or PDE5 was observed in nerve fibers or nerve endings (Table 1) .
Discussion
Although it has been suggested that the clitoris is connected with the normal progress of the female sexual arousal cycle and orgasm phase, only very few studies have investigated the physiology of this genital organ. [5] [6] [7] Based on these findings, a role of the NO/cyclic GMP system in the female sexual arousal process has been proposed. The central role of cyclic AMP and cyclic GMP and PDE isoenzymes in the control of various tissue functions has been established and the pharmacological concept of increasing tissue levels of cyclic nucleotides, for example, by the use of selective PDE inhibitors, to treat diseases of the urogenital tract, such as urinary stone disease (ureterolithiasis), urinary Cyclic GMP binding proteins in the human clitoris S Ückert et al incontinence, symptoms of the so-called benign prostatic syndrome including lower urinary tract symptoms and bladder outlet obstruction, has been evaluated in clinical studies. [18] [19] [20] Based on the hypothesis that the response to sexual stimulation in women is, in part, mediated by the same biological pathways than in the male, it has been speculated as to whether the application of PDE inhibitors may also facilitate female genital smooth muscle relaxation, thus resulting in an improvement of subnormal arousal. 21 A few efforts were made in order to characterize PDE isoenzymes of the human clitoris; however, these studies were mainly limited to the cyclic GMP-specific PDE5, whereas other cyclic GMP- Cyclic GMP binding proteins in the human clitoris S Ückert et al binding PDE isoenzymes, such as PDE2, PDE3, PDE9, PDE10 or PDE11, or other key proteins of the NO/cyclic GMP pathway, such as cGK, have either not or only randomly been investigated. 6, 7 The present study demonstrates the presence of the cyclic GMP-binding PDE2 (cyclic AMP PDE, stimulated by cyclic GMP) in the smooth muscle of arterial vessels interspersing the clitoral subepidermal and sinusoidal space. Those vessels are also characterized by the expression of PDE5 and cGKI. The observation that PDE5 is localized in clitoral vascular smooth muscle is in contrast to the findings by Oelke et al., 7 who reported that PDE5 is limited to the non-vascular smooth muscle of the clitoral erectile tissue. The presence of the cyclic GMP-binding, cyclic AMP-degrading PDE2, the cyclic GMP-specific PDE5 and cGKI in clitoral vascular smooth muscle implies that the NO/cyclic GMP signaling and related key enzymes are involved in the control of clitoral blood flow. Moreover, given the fact that PDE2 does mainly hydrolize cyclic AMP, it seems likely that the cyclic GMP system is not the only signal transduction cascade contributing to the control of clitoral engorgement and tumescence and that both pathways may work synergistically together. In humans, the dual substrate PDE11 has been shown to be abundantly present mainly in striated skeletal muscle, the prostate and testes. However, with regard to the male urogenital tract, the physiological significance of this isoenzyme and the inhibition of its activity by compounds such as tadalafil has not yet been fully evaluated and understood. 22 In the human clitoris, the expression of mRNA transcripts specifically encoding for PDE11A was shown by means of real time-PCR analysis. In clitoral tissue, the degree of PDE11A mRNA expression was significantly higher than in human penile erectile tissue (corpus cavernosum). 7 Nevertheless, the localization of PDE11 in the clitoris has not yet been addressed. The present study, for the first time, presents evidence that the enzyme is exclusively located in neuronal structures, thus suggesting an involvement of the PDE isoenzyme in local neurotransmission. Aside from PDE2 and PDE3, both known to be regulated by the binding of cyclic GMP to specific allosteric sites of the isoenzymes, the cGKI has been identified a major target for cyclic GMP downstream the signal transduction cascade. The significance of cGKI in controlling the function of genital vascular and non-vascular smooth muscle has mainly been investigated using animal models, and alterations in the expression and activity of cGKI have been related to the on-set of male erectile dysfunction. 23 So far, only two studies have attempted to evaluate the expression of cGKI in human genital tissues. Waldkirch et al., 24 using conventional immunohistochemistry and western blot analysis, demonstrated the expression of cGKI within the smooth musculature and the endothelium of penile arteries and cavernous sinusoids where the enzyme was found colocalized with cyclic GMP and eNOS. Ü ckert et al. 25 observed immunosignals specific for cGKI (isoform Ib) in vascular and non-vascular smooth muscle of the vaginal wall. Both authors assumed a role of the protein kinase in the control of smooth muscle of the penile erectile tissue or vagina, respectively.
Interestingly, in the clitoris, immunolabeling specific for PDE2 was also seen in cells similar to so-called ICs, characterized by the expression of vimentin, located in the basal epidermal layer. The identification of IC is based mainly on ultrastructural criteria: spindle-shaped cells with an extended smooth endoplasmic reticulum and bundles of intermediate filaments. However, such characteristics may vary in different organs. 26, 27 ICs have also been identified by immunoreactivity for the transmembrane receptor protein c-kit, the gap junction protein connexin 43 or vimentin, an intermediate filament subunit of mesenchymal cells. 13, 14, 16 Usually, ICs can be found adjacent to their target cells, such as smooth muscle cells, epithelial cells or nerve endings. 28 It has been suggested that ICs may have a pivotal role as so-called pacemakers and mediators of neurotransmission in the bladder, urethra and penile erectile tissue. [14] [15] [16] [17] 29 The role of ICs in the clitoris remains to be established. Some hypotheses have been proposed: adult mesenchymal cells, which might participate in (a) intercellular signaling or (b) chemo-mechanical transducing or act as (c) players in pace-making through direct cell-to-cell communication.
In conclusion, the results presented are in favor of a role of the cyclic GMP signaling and related cyclic cGMP-binding proteins, such as PDE2, PDE5 and cGKI, in the control of clitoral blood flow. Moreover, it seems likely that PDE2 and PDE11 are also involved in the mechanism of local (neuro)transmission in the clitoris.
